Coagulation Factor Activity and 90-Day Stroke Outcomes for 171 Patients

171 stroke patients were analyzed in a retrospective cohort study from May 2019 to March 2023. The research, authored by Yunyan Ye, measured coagulation factor activity within 24 hours of admission to assess associations with 90-day functional outcomes in ischemic and hemorrhagic stroke subtypes.

Use Cases

• Modeling 90-day prognosis in hemorrhagic stroke based on coagulation factor VII and IX activity levels.
• Investigating subtype-specific biomarker associations for stroke outcomes using multivariable logistic regression.
• Analyzing correlations between coagulation factor XI activity and clinical severity scores (GCS, NIHSS) in hemorrhagic stroke patients.

Strengths

• Includes data for 171 stroke patients with detailed clinical and laboratory measurements.
• Study design specifies a clear time range (May 2019 to March 2023) and measurement window (within 24 hours of admission).
• Analysis includes multivariable logistic regression results with odds ratios and confidence intervals for key factors.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count for the underlying dataset is unknown, which may limit suitability assessment.
• The 49.2 KB file size suggests a very limited scope of data, likely summary statistics rather than a full patient-level dataset.

Provenance

Source

figshare

Collection Method

Retrospective cohort study of patients recruited from a clinical setting.

Time Range

May 2019 to March 2023

Freshness

Last updated 2026-05-29 06:07:40; freshness should be verified.